Company intelligence / Profile preview

Dopa Pharmaceutical

Gainesville, Florida, United States

Ownership: Private
Development stage: Other

Overview

Serodopa Therapeutics is a biopharmaceutical company focused on developing novel treatments for central nervous system (CNS) disorders and medical countermeasures. The company utilizes prodrug technology and drug repurposing to create therapies with streamlined pathways to regulatory approval. Its lead programs target critical areas such as drug overdose reversal and the management of motor fluctuations in neurological conditions. Headquartered in Gainesville, Florida, Serodopa aims to address significant unmet needs in underserved patient populations through agile and efficient drug development.

Therapeutic areas: NeurologyOther
Modalities: Small moleculeProdrug
Industry: Biotech

Beyond the preview

Go deeper on Dopa Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopa Pharmaceutical.

Explore the full profile